Does TEDUGLUTIDE Cause Poor venous access? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Poor venous access have been filed in association with TEDUGLUTIDE (Gattex). This represents 0.3% of all adverse event reports for TEDUGLUTIDE.
24
Reports of Poor venous access with TEDUGLUTIDE
0.3%
of all TEDUGLUTIDE reports
4
Deaths
19
Hospitalizations
How Dangerous Is Poor venous access From TEDUGLUTIDE?
Of the 24 reports, 4 (16.7%) resulted in death, 19 (79.2%) required hospitalization.
Is Poor venous access Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TEDUGLUTIDE. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does TEDUGLUTIDE Cause?
Vascular device infection (1,009)
Weight decreased (991)
Product dose omission issue (937)
Diarrhoea (779)
Abdominal pain (714)
Nausea (682)
Weight increased (631)
Dehydration (615)
Vomiting (585)
Death (527)
What Other Drugs Cause Poor venous access?
VEDOLIZUMAB (1,043)
INFLIXIMAB (917)
INFLIXIMAB-DYYB (782)
ECULIZUMAB (555)
HUMAN IMMUNOGLOBULIN G (504)
NATALIZUMAB (422)
RITUXIMAB (299)
TOCILIZUMAB (287)
METHOTREXATE (257)
ABATACEPT (249)
Which TEDUGLUTIDE Alternatives Have Lower Poor venous access Risk?
TEDUGLUTIDE vs TEDUGLUTIDE\WATER
TEDUGLUTIDE vs TEGAFUR
TEDUGLUTIDE vs TEGAFUR\URACIL
TEDUGLUTIDE vs TEGASEROD
TEDUGLUTIDE vs TEGRETOL